# Step 193 — DE09.033 acceptance closure and next CPP gap

2026-10-26 (America/Toronto). **DE09.033: SATISFIED — VERIFIED WITH QUALIFICATIONS**, limited to the approved native prescription earliest-pickup capability. Owner-reported manual verification completes the basic UI acceptance alongside retained automated evidence. **PC07.01 remains PARTIAL; inventory unchanged at 7 mandatory-gap IDs / 3 packages.** Documentation only; no new execution or implementation.

## 1. Authority and evidence reused

- [Step 191A](267-step191a-de09-033-earliest-pickup-contract.md): CDS-S Data Dictionary v2.1 Final, published 2026-06-05, `Data Dictionary!A159:K159`, DE09.033 **To Be Picked Up When**. Exact definition: “The earliest date and time on which the dispensed medication is expected to be picked up.” Classification: **M / S**, mandatory product support and store-only. Retain existing Baseline/CDS-S release-applicability qualifications.
- [Step 191B](268-step191b-de09-033-earliest-pickup-implementation.md): approved Day/Minute representation, tenant clinical-zone validation, independent presence/clear handling, audit, linked correction review, RowVersion and immutable artifacts; retained backend/frontend/build evidence.
- [Step 192 and its follow-up](269-step192-de09-033-local-acceptance-readiness.md): verified development environment and migration 0093 application; earlier pending-migration statements are historical and superseded by its follow-up.
- [Step 190](266-step190-independent-gap-implementation-assessment.md), [Step 115](150-step115-pc07-01-medication-de09-requirement-resolution.md) and [Step 137 Q7](204-step137-pc07-01-clinical-source-contract-resolution.md): retained remaining CPP elements and source/clinical-policy decisions. No new authoritative extraction or external investigation was needed.

## 2. Owner-reported manual acceptance — PASS

The owner explicitly confirmed the following supplied checklist as **PASS**, in **local-dev-fresh**. These are owner-reported normal UI outcomes, not a newly instrumented Codex session or a claim that Codex performed the saves.

| Assertion | Owner-reported result |
|---|---|
| Date-only **November 3, 2026** survives save/reopen unchanged | **PASS** |
| Date-only display states **time not specified** | **PASS** |
| **November 3, 2026 at 09:30**, **America/Toronto / UTC−05:00**, survives save/reopen | **PASS** |
| Explicit clear survives save/reopen and displays **Not recorded** | **PASS** |
| New controls remain readable in a narrow window | **PASS** |

The owner separately accepted the prescription-list layout fix after pickup/review text was moved out of the button area into a wrapping block under the medication. That layout PASS is supplementary UI evidence; it does not prove signing or correction lifecycle execution.

No additional manual scenario is claimed. In particular, the owner did **not** report a new manual DST-gap/repeated-hour case, deliberate stale/unauthorized write, linked-correction finalization/review, artifact hash comparison or deployed audit/RowVersion inspection. Exact executed fixture identities, save timestamps, audit IDs and loaded binary hashes were not supplied with this PASS and are not reconstructed from Step 192's candidate fixtures.

## 3. Automated evidence reconciliation

| Retained evidence | Result / accounting boundary |
|---|---|
| Focused pickup backend | **20 PASS**; included in the backend total below |
| Focused pickup frontend | **6 PASS**; included in the frontend total below |
| Relevant backend regression coverage | **162 distinct cases, all latest outcomes PASS** |
| Relevant frontend regression coverage | **18 distinct cases, all latest outcomes PASS** |
| Affected-project build / TypeScript | **PASS / PASS** |
| Build warnings | **Six NU1900 NuGet vulnerability-metadata warnings**, caused by unavailable vulnerability metadata; do not describe this as a warning-free build or a clean vulnerability assessment |

The totals are not additive: **20 is part of 162 and 6 is part of 18**. Step 191B correlated latest outcomes across its broader run and targeted remedies by stable TRX test ID; this report does not claim one fresh 162-PASS run. No build, automated suite or browser test was rerun.

Retained focused coverage establishes date/offset round trips, named-zone/DST validation, omission/null semantics, malformed input rejection, ownership/tenant/permission boundaries, stale RowVersion rejection, transactional audit rollback, linked correction inheritance/review on both finalization paths, and original/legacy artifact preservation. It complements the owner's visual/save/reopen checks without turning isolated security/lifecycle evidence into deployed manual observations.

The subsequent layout fix retained the required checkbox's association with its signing form. Its recorded Web build and isolated browser checks at 1600px/1024px passed; unchecked review blocked form validity and checked review submitted the expected value. Those checks are not additional cases in the Step 191B totals and do not claim a clinical signature occurred.

## 4. Migration and remaining qualifications

Step 192's targeted follow-up verified:

- Tenant `local-dev-fresh`, UID `f94c6ecd-4417-483e-8a94-0507cf8384c2`; database **MicroEMR_LocalDev_Fresh** on the established development SQL endpoint.
- Ledger entry **0093-prescription-earliest-pickup**, timestamp `2026-10-26T15:53:23.0062913`, ScriptHash `1D3F745AEF4870CE7C8804B7BEB1B670A08EF7348F94B09319E571271A5EC596`, matching the controlled canonical hash.
- Pickup column, validator, constraint and create/update/finalization parameters present. **Do not reapply 0093.** No migration or database check was repeated in this step.

Qualifications retained:

1. Closure covers optional native prescription **Day/Minute** capture, authorized retrieval and the approved unknown/clear/correction behavior. It does not establish all external-import precisions, destination-specific timezone workflows, dispensing readiness, stock, transmission or regulatory dispensing restrictions.
2. Manual linked-correction review/finalization and deployed audit/artifact correlation remain **not manually verified**. Their retained automated evidence supports the implementation qualification; do not report those manual scenarios as executed.
3. Owner save/reopen PASS demonstrates use of the feature in the reported environment. It does not independently attest to deployed binary hashes, a complete runtime release or all deployment permissions. Step 192's outstanding recovery-plan evidence is not retroactively marked complete; no backup/restore was performed or verified here.
4. The store-only field does not require new prescription/CPP PDF content. Existing immutable artifact and historical precision semantics remain; ordinary supersession status/link/RowVersion changes are distinct from altering original clinical facts or artifact bytes.
5. Existing source/release applicability and external certification acceptance qualifications remain. This is an internal subordinate acceptance decision, not OntarioMD approval. External correspondence remains deferred under the owner's instructions.

## 5. Closure decision

**DE09.033 — SATISFIED — VERIFIED WITH QUALIFICATIONS.** The field's required time-bearing storage capability is implemented, isolated integrity/lifecycle verification passes, migration application is verified, and the owner reports successful date-only, timed, clear and narrow-window UI acceptance. The remaining qualifications above are explicit and do not justify repeatedly reopening the completed basic pickup work.

This report supersedes the earlier DE09.033 “not implemented” / “manual acceptance deferred” disposition **only for the accepted scope**. It does not rewrite earlier reports, erase their execution boundaries or claim every planned manual scenario is now PASS.

**PC07.01 stays PARTIAL.** DE09.033 is subordinate to an already-counted parent; its closure removes **zero top-level IDs**.

## 6. Remaining PC07.01 scope and next local element

Retain the existing residuals, excluding the now-accepted DE09.033 slice:

| Residual | Current dependency / scope |
|---|---|
| DE09.005 source-backed DIN | Designated drug-data identity/provenance; external-source work remains deferred |
| DE09.030 target dispensing facility address | Explicit order-owned address and appropriate entered-fact/source policy |
| **DE09.031 target dispensing facility name** | Explicit order-owned human-readable destination name; recommended next local slice |
| DE09.032 target dispensing facility identifier | Real namespace/source-qualified identity; never substitute an EMR artifact/provider UID or invent registry verification |
| DE09.034 reason / DE09.035 protocol | Actual supplied coded/reference sources and applicability; preserve the difference between mandatory element support and optional terminology conformance |
| Wider DE09.027 authority semantics | Governing applicability and clinical authority remain unresolved; accepted native paper Yes / Not recorded behavior is retained |
| Applicable source/ownership/full-detail/audience correlation | Resolve demonstrated remaining omissions without merging list/order records by name or printing store-only/private data indiscriminately |

Completed dose, native medication/allergy, Family, Risk, mobile and PC07.10 work remain accepted. No new missing field is inferred from an old report predating those closures.

**Next element: DE09.031 — Targeted Dispensing Facility – Service Location Name.** Step 115 retains its authoritative locator as CDS-S Data Dictionary v2.1 `Data Dictionary!D157:F157`, **M / S**, identifying the human-readable dispensing location name, distinct from patient address, prescriber identity or clinic name. This is the existing mapping, not a fresh verbatim definition extraction.

**Local readiness: CONDITIONAL.** A prescriber-entered per-order location name can be implemented and meaningfully round-tripped locally without a pharmacy directory or transmission partner **if the owner approves that entered-fact contract**. It must be represented as supplied text, not registry-verified identity. Step 137 already proposed explicitly supplied facility facts as an alternative to a real approved source; it did not approve that alternative or establish certification completeness. DE09.032 and any required source-backed identification remain separate. A name alone does not close the destination group or PC07.01.

## 7. Recommended Step 194 — DE09.031 bounded local contract

Prepare **DE09.031 target dispensing facility name contract/readiness**, using the retained definition and only the relevant existing prescription DTO/UI/persistence/snapshot paths. Avoid another broad certification assessment or an external integration search.

Settle the following local decisions with recommended defaults:

- **Ownership/source:** optional explicitly supplied native prescription-order name; clinician confirms that recording the intended location is useful for evaluation. No automatic copy from patient/prescriber/clinic, external directory or medication-list record.
- **Clinical meaning/applicability:** label as intended dispensing location, not confirmed routing, reservation, delivery or dispensing; owner/clinician confirms unknown and change/correction behavior. Reuse presence-aware omission/clear and existing Draft/linked-correction conventions where applicable; do not invent a new review gate merely by analogy with pickup.
- **Text contract:** choose a justified bounded Unicode name representation, whitespace/empty handling and safe full-detail display. Do not invent a regulatory length or silently abbreviate names. Confirm limits against the actual existing model before SQL design.
- **History/audience:** audit changes, preserve RowVersion/tenant/patient/original-prescriber protections and old artifacts; decide prospective snapshot retention. Store-only support does not automatically expand print, CPP cards or navigation.
- **Boundary:** DE09.030 address, DE09.032 registry/identifier, DIN, reason/protocol and transmission remain outside this first implementation slice. If local name capture cannot meet the agreed source/association contract, record that precise blocker rather than fabricate a directory or mark the field complete.

After that contract is approved and implementation separately requested, scope one name field through existing Application validation, Infrastructure/stored procedures and Bootstrap entry/Detail, with focused round-trip, omission/clear, audit/concurrency/authorization and historical compatibility checks. No implementation, estimate commitment, new schema object or owner approval is inferred in Step 193. This follows Step 190's one-slice-at-a-time local CPP priority while keeping external work deferred.

## 8. Inventory and documentation record

| Package | Remaining mandatory IDs | Count |
|---|---|---:|
| Prescribing | PC04.01, PC04.06, PC04.07, PC04.09, PC04.14 | 5 |
| CPP | PC07.01 | 1 |
| Scheduling | PC09.03 | 1 |
| **Total** | **7 IDs / 3 nonempty packages** | **7** |

Only `270-step193-de09-033-acceptance-closure.md` was created. Documentary review checked exact acceptance attribution, non-additive test counts, migration follow-up precedence, qualified subordinate closure and unchanged inventory. No source/SQL change, database access, clinical write, migration, build/test, deployment, Git operation, external correspondence or unrelated assessment occurred. Existing work preserved. Stop after documentation.
